Figure 4
Primary erythroid cells from MPD samples are selectively inhibited by lestaurtinib. (A) Proliferation at 100 nM: comparison of means between MPD samples (34.6% ± 20.1%) and NBM controls (71.8% ± 8.9%) is significant (P = .03). (B) Proliferation at 100 nM: comparison of means between MPD samples stratified by presence (V617F+, n = 11, mean 28.1% ± 4.8%) or absence (V617F-, n = 7 mean 44.8% ± 8.7%) of JAK2 versus NBM controls (P = .006 by ANOVA). The difference of means between V617F+and V617− samples did not reach statistical significance (P = .08 Student t-test). Means, standard error of the mean (shorter horizontal lines), and standard deviation (longer horizontal lines) are depicted for each group.

Primary erythroid cells from MPD samples are selectively inhibited by lestaurtinib. (A) Proliferation at 100 nM: comparison of means between MPD samples (34.6% ± 20.1%) and NBM controls (71.8% ± 8.9%) is significant (P = .03). (B) Proliferation at 100 nM: comparison of means between MPD samples stratified by presence (V617F+, n = 11, mean 28.1% ± 4.8%) or absence (V617F-, n = 7 mean 44.8% ± 8.7%) of JAK2 versus NBM controls (P = .006 by ANOVA). The difference of means between V617F+and V617 samples did not reach statistical significance (P = .08 Student t-test). Means, standard error of the mean (shorter horizontal lines), and standard deviation (longer horizontal lines) are depicted for each group.

Close Modal

or Create an Account

Close Modal
Close Modal